Latest Happenings at VLST
Novel Therapeutics
Preclinical studies completed for VLST-007 Targeting Autoimmune & Inflammatory Diseases
VLST Platform Yields More Than 70 Virulence Targets
VLST Corporation is dedicated to the streamlined discovery and development of novel therapeutics for the treatment of autoimmune and inflammatory disorders.

